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Résumé en
anglais
BACKGROUND: Huntington's disease is caused by a CAG repeat expansion in the
huntingtin gene, HTT. Age at onset has been used as a quantitative phenotype in
genetic analysis looking for Huntington's disease modifiers, but is hard to define and
not always available. Therefore, we aimed to generate a novel measure of disease
progression and to identify genetic markers associated with this progression
measure.
METHODS: We generated a progression score on the basis of principal component
analysis of prospectively acquired longitudinal changes in motor, cognitive, and
imaging measures in the 218 indivduals in the TRACK-HD cohort of Huntington's
disease gene mutation carriers (data collected 2008-11). We generated a parallel
progression score using data from 1773 previously genotyped participants from the
European Huntington's Disease Network REGISTRY study of Huntington's disease
mutation carriers (data collected 2003-13). We did a genome-wide association
analyses in terms of progression for 216 TRACK-HD participants and 1773 REGISTRY
participants, then a meta-analysis of these results was undertaken.
FINDINGS: Longitudinal motor, cognitive, and imaging scores were correlated with
each other in TRACK-HD participants, justifying use of a single, cross-domain
measure of disease progression in both studies. The TRACK-HD and REGISTRY
progression measures were correlated with each other (r=0·674), and with age at
onset (TRACK-HD, r=0·315; REGISTRY, r=0·234). The meta-analysis of progression
in TRACK-HD and REGISTRY gave a genome-wide significant signal (p=1·12 × 10) on
chromosome 5 spanning three genes: MSH3, DHFR, and MTRNR2L2. The genes in
this locus were associated with progression in TRACK-HD (MSH3 p=2·94 × 10DHFR
p=8·37 × 10 MTRNR2L2 p=2·15 × 10) and to a lesser extent in REGISTRY (MSH3
p=9·36 × 10DHFR p=8·45 × 10MTRNR2L2 p=1·20 × 10). The lead single nucleotide
polymorphism (SNP) in TRACK-HD (rs557874766) was genome-wide significant in the
meta-analysis (p=1·58 × 10), and encodes an aminoacid change (Pro67Ala) in MSH3.
In TRACK-HD, each copy of the minor allele at this SNP was associated with a 0·4
units per year (95% CI 0·16-0·66) reduction in the rate of change of the Unified
Huntington's Disease Rating Scale (UHDRS) Total Motor Score, and a reduction of
0·12 units per year (95% CI 0·06-0·18) in the rate of change of UHDRS Total
Functional Capacity score. These associations remained significant after adjusting for
age of onset.
INTERPRETATION: The multidomain progression measure in TRACK-HD was
associated with a functional variant that was genome-wide significant in our meta-
analysis. The association in only 216 participants implies that the progression
measure is a sensitive reflection of disease burden, that the effect size at this locus is
large, or both. Knockout of Msh3 reduces somatic expansion in Huntington's disease
mouse models, suggesting this mechanism as an area for future therapeutic
investigation.
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